Abstract
A number of instruments are available to clinicians to assess cognitive and neuropsychiatric features of neurocognitive disorders in older adults, from preclinical and prodromal stages through to more severe stages of dementia. This chapter provides a comprehensive overview and discussion of the key characteristics to consider when selecting a screening instrument to support accurate and timely assessment of cognitive changes and neuropsychiatric symptoms, both of which are core features of neurocognitive disorders. Particular consideration must be given to factors such as the assessment setting (e.g., acute care versus residential care environment), the population for which a measure was developed, and the context in which the instrument was validated. When selecting an instrument, clinicians must also consider possible population-based bias effects as a result of use in culturally and linguistically diverse populations or due to differences in educational attainment. Improving understanding of the diversity in measures available to assist clinicians in differing care contexts is fundamental so that the best possible care and treatment plans can be implemented, and better support provided to next of kin and caregivers (both formal and informal caregivers).
References
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA (1988) Cornell scale for depression in dementia. Biol Psychiatry 23:271–284
Amodeo S, Mainland BJ, Herrmann N, Shulman KI (2015) The times they are a-changin’ clock drawing and prediction of dementia. J Geriatr Psychiatry Neurol 28:145–155
Arevalo-Rodriguez I, Smailagic N, Roqué I, Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S (2015) Mini-Mental State Examination (MMSE) for the detection of Alzheimer’s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Dat Syst Rev 3:CD010783. doi:10.1002/14651858.CD010783.pub2
Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement 11:718–726
Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A (2000) The Mini-Cog: a cognitive‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry 15:1021–1027
Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M (2005) Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc 53:871–874
Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA (2002) The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 50:530–534
Carnero-Pardo C, Espejo-Martinez B, Lopez-Alcalde S, Espinosa-Garcia M, Saez-Zea C, Vilchez-Carrillo R, Hernandez-Torres E, Navarro-Espigares JL (2011) Effectiveness and costs of phototest in dementia and cognitive impairment screening. BMC Neurol 11:1
Carpenter CR, Bassett ER, Fischer GM, Shirshekan J, Galvin JE, Morris JC (2011) Four sensitive screening tools to detect cognitive dysfunction in Geriatric Emergency Department Patients: brief Alzheimer’s screen, short blessed test, Ottawa 3DY, and the caregiver-completed AD8. Acad Emerg Med 18:374–384
Castanho TC, Amorim L, Zihl J, Palha JA, Sousa N, Santos NC (2014) Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci 6:16
Chen CW, Chu H, Tsai CF, Yang HL, Tsai JC, Chung MH, Liao YM, Chi MJ, Chou KR (2015) The reliability, validity, sensitivity, specificity and predictive values of the Chinese version of the Rowland Universal Dementia Assessment Scale. J Clin Nurs 24:3118–3128
Cheung G, Clugston A, Croucher M, Malone D, Mau E, Sims A, Gee S (2015) Performance of three cognitive screening tools in a sample of older New Zealanders. Int Psychogeriatr 27:981–989
Cohen-Mansfield J, Marx MS, Rosenthal AS (1989) A description of agitation in a nursing home. J Gerontol 44:M77–M84
Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, Thom VM, Nash KJE, Elhamoui H, Milligan R, Patel AS, Tsivos DV, Wing T, Phillips E, Kellman SM, Shackleton HL, Singleton GF, Neale BE, Watton ME, Cullum S (2016) Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Dat Syst Rev 1:CD011145. doi:10.1002/14651858.CD011145.pub2
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314
Cummings-Vaughn LA, Chavakula NN, Malmstrom TK, Tumosa N, Morley JE, Cruz-Oliver DM (2014) Veterans Affairs Saint Louis University mental status examination compared with the Montreal cognitive assessment and the short test of mental status. J Am Geriatr Soc 62:1341–1346
de Leonni Stanonik M, Licata CA, Walton NC, Lounsbury JW, Hutson RK, Dougherty JH (2005) The self test: a screening tool for dementia requiring minimal supervision. Int Psychogeriatr 17:669–678
de Medeiros K, Robert P, Gauthier S, Stella F, Politis A, Leoutsakos J, Taragano F, Kremer J, Brugnolo A, Porsteinsson AP, Geda YE, Brodaty H, Gazdag G, Cummings J, Lyketsos C (2010) The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr 22:984–994
del Campo N, Payoux P, Djilali A, Delrieu J, Hoogendijk EO, Rolland Y, Cesari M, Weiner MW, Andrieu S, Vellas B (2016) Relationship of regional brain β-amyloid to gait speed. Neurology 86:36–43
Dougherty JH Jr, Cannon RL, Nicholas CR, Hall L, Hare F, Carr E, Dougherty A, Janowitz J, Arunthamakun J (2010) The computerized self test (CST): an interactive, internet accessible cognitive screening test for dementia. J Alzheimers Dis 20:185–195
Douglas VC, Neuhaus J, Johnson J, Racine C, Miller BL, Josephson SA (2011) Dementia = (MC) 2: a four-item screening test for mild cognitive impairment and dementia. Alzheimer Dis Assoc Disord 25:220
Ehreke L, Luck T, Luppa M, König H-H, Villringer A, Riedel-Heller SG (2011) Clock drawing test–screening utility for mild cognitive impairment according to different scoring systems: results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Int Psychogeriatr 23:1592–1601
Folstein MF, Folstein SE, Mchugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Fong TG, Jones RN, Rudolph JL, Yang FM, Tommet D, Habtemariam D, Marcantonio ER, Langa KM, Inouye SK (2011) Development and validation of a brief cognitive assessment tool: the sweet 16. Arch Intern Med 171:432–437
Freitas S, Simões MR, Alves L, Duro D, Santana I (2012) Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia. J Geriatr Psychiatry Neurol 25:146–154
Freitas S, Simões MR, Alves L, Santana I (2013) Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 27:37–43
Galvin J, Roe C, Powlishta K, Coats M, Muich S, Grant E, Miller J, Storandt M, Morris J (2005) The AD8 A brief informant interview to detect dementia. Neurology 65:559–564
Gates NJ, Kochan NA (2015) Computerized and on-line neuropsychological testing for late-life cognition and neurocognitive disorders: are we there yet? Curr Opin Psychiatry 28:165–172
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT (2016) Why has therapy development for dementia failed in the last two decades? Alzheimers Dement 12:60–64
Gitlin LN, Kales HC, Lyketsos CG (2012) Nonpharmacologic management of behavioral symptoms in dementia. JAMA 308:2020–2029
Gitlin LN, Marx KA, Stanley IH, Hansen BR, van Haitsma KS (2014) Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures. Int Psychogeriatr 26:1805–1848
Gold DA (2012) An examination of instrumental activities of daily living assessment in older adults and mild cognitive impairment. J Clin Exp Neuropsychol 34:11–34
Hancock P, Larner A (2011) Test your memory test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry 26:976–980
Heinik J, Kavé G (2015) An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer’s disease. Int Psychogeriatr 27:785–791
Hellmuth J, Mirsky J, Heuer H, Matlin A, Jafari A, Garbutt S, Widmeyer M, Berhel A, Sinha L, Miller B (2012) Multicenter validation of a bedside antisaccade task as a measure of executive function. Neurology 78:1824–1831
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR (2013) Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 36:242–250
Hsieh H, Mcgrory S, Leslie F, Dawson K, Ahmed S, Butler CR, Rowe JB, Mioshi E, Hodges JR (2014) The mini-Addenbrooke’s cognitive examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord 39:1–11
Iracleous P, Nie JX, Tracy CS, Moineddin R, Ismail Z, Shulman KI, Upshur RE (2010) Primary care physicians’ attitudes towards cognitive screening: findings from a national postal survey. Int J Geriatr Psychiatry 25:23–29
Ismail Z, Rajji TK, Shulman KI (2010) Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 25:111–120
Ismail Z, Emeremni CA, Houck PR, Mazumdar S, Rosen J, Rajji TK, Pollock BG, Mulsant BH (2013a) A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in treatment of agitation and psychosis associated with dementia. Am J Geriatr Psychiatry 21:78–87
Ismail Z, Mulsant BH, Herrmann N, Rapoport M, Nilsson M, Shulman K (2013b) Canadian Academy Of Geriatric Psychiatry survey of brief cognitive screening instruments. Can Geriatr J 16:54–60
Ismail Z, Malick A, Smith EE, Schweizer T, Fischer C (2014) Depression versus dementia: is this construct still relevant? Neurodegener Dis Manag 4:119–126
Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement 12:195–202
Jacinto AF, Brucki SMD, Porto CS, de Arruda Martins M, de Albuquerque Citero V, Nitrini R (2014) Suggested instruments for general practitioners in countries with low schooling to screen for cognitive impairment in the elderly. Int Psychogeriatr 26:1121–1125
Jorm A, Scott R, Cullen J, Mackinnon A (1991) Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 21:785–790
Jubb MT, Evans JJ (2015) An investigation of the utility of the Addenbrooke’s cognitive examination III in the early detection of dementia in memory clinic patients aged over 75 years. Dement Geriatr Cogn Disord 40:222–232
Kales HC, Gitlin LN, Lyketsos CG (2015) Assessment and management of behavioral and psychological symptoms of dementia. BMJ 350:h369
Kandiah N, Zhang A, Bautista DC, Silva E, Ting SKS, Ng A, Assam P (2016) Early detection of dementia in multilingual populations: visual Cognitive Assessment Test (VCAT). J Neurol Neurosurg Psychiatry 87:156–160
Klekociuk S, Summers J, Vickers J, Summers MJ (2014) Reducing false positive diagnoses in mild cognitive impairment: the importance of comprehensive neuropsychological assessment. Eur J Neurol 21:1330. e83
Koski L (2013) Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis 36:6–18
Ladas A, Frantzidis C, Bamidis P, Vivas AB (2014) Eye blink rate as a biological marker of mild cognitive impairment. Int J Psychophysiol 93:12–16
Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE (2013) Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc 61:2181–2185
Lanctôt KL, Agüera-Ortiz L, Brodaty H, Francis PT, Geda YE, Ismail Z, Marshall GA, Mortby ME, Onyike CU, Padala PR (2016) Apathy associated with neurocognitive disorders: recent progress and future directions. Alzheimers Dement 13(1):84–100. doi:10.1016/j.jalz.2016.05.008. Epub 2016 Jun 27
Larner A (2012) Screening utility of the Montreal Cognitive Assessment (MoCA): in place of–or as well as–the MMSE? Int Psychogeriatr 24:391–396
Lin FR, Metter EJ, O’Brien RJ, Resnick SM, Zonderman AB, Ferrucci L (2011) Hearing loss and incident dementia. Arch Neurol 68:214–220
Lischka AR, Mendelsohn M, Overend T, Forbes D (2012) A systematic review of screening tools for predicting the development of dementia. Can J Aging/La Rev Can Vieil 31:295–311
Lu J, Li D, Li F, Zhou A, Wang F, Zuo X, Jia X-F, Song H, Jia J (2011) Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol 24:184–190
Lyketsos CG, Miller DS (2012) Addressing the Alzheimer’s disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes. Alzheimers Dement 8:60–64
Malmstrom TK, Voss V, Cruz-Oliver D, Cummings-Vaughn L, Tumosa N, Grossberg G, Morley J (2015) The Rapid Cognitive Screen (RCS): a point-of-care screening for dementia and mild cognitive impairment. J Nutr Health Aging 19:741–744
Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D (2013) Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease. BMC Psychol 1:1
Mathuranath P, Nestor P, Berrios G, Rakowicz W, Hodges J (2000) A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 55:1613–1620
Mccarten JR, Anderson P, Kuskowski MA, Mcpherson SE, Borson S (2011) Screening for cognitive impairment in an elderly veteran population: acceptability and results using different versions of the Mini-Cog. J Am Geriatr Soc 59:309–313
Milian M, Leiherr A-M, Straten G, Müller S, Leyhe T, Eschweiler GW (2012) The Mini-Cog versus the mini-mental state examination and the clock drawing test in daily clinical practice: screening value in a German Memory Clinic. Int Psychogeriatr 24:766–774
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006) The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078–1085
Mitchell AJ (2013) The Mini-Mental State Examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Cognitive screening instruments. Springer, London
Mortby ME, Anstey KJ (2015) Mental health and aging. In: Pachana AN (ed) Encyclopedia of geropsychology. Springer Singapore, Singapore
Naqvi RM, Haider S, Tomlinson G, Alibhai S (2015) Cognitive assessments in multicultural populations using the Rowland Universal Dementia Assessment Scale: a systematic review and meta-analysis. Can Med Assoc J 187:E169–E175
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699
Nielsen TR, Phung TKT, Chaaya M, Mackinnon A, Waldemar G (2015) Combining the rowland universal dementia assessment scale and the informant questionnaire on cognitive decline in the elderly to improve detection of dementia in an arabic-speaking population. Dement Geriatr Cogn Disord 41:46–54
Odenheimer G, Borson S, Sanders AE, Swain-Eng RJ, Kyomen HH, Tierney S, Gitlin L, Forciea MA, Absher J, Shega J, Johnson J (2013) Quality improvement in neurology: dementia management quality measures (executive summary). Am J Occup Ther 67:704–710
Onoda K, Hamano T, Nabika Y, Aoyama A, Takayoshi H, Nakagawa T, Ishihara M, Mitaki S, Yamaguchi T, Oguro H (2013) Validation of a new mass screening tool for cognitive impairment: cognitive assessment for dementia, iPad version. Clin Interv Aging 8:353–360
Razavi M, Tolea MI, Margrett J, Martin P, Oakland A, Tscholl DW, Ghods S, Mina M, Galvin JE (2014) Comparison of two informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE. Alzheimer Dis Assoc Disord 28:156
Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139:1136–1139
Reisberg B, Auer SR, Monteiro IM (1996) Behavioral pathology in Alzheimer’s disease (BEHAVE-AD) rating scale. Int Psychogeriatr 8(Suppl 3):301–308; discussion 351–4
Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE (2013) Comparative accuracies of two common screening instruments for classification of Alzheimer’s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement 9:529–537
Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O, Caci H, Borg M, Brocker P, Bedoucha P (2002) The apathy inventory: assessment of apathy and awareness in Alzheimer’s disease, Parkinson’s disease and mild cognitive impairment. Int J Geriatr Psychiatry 17:1099–1105
Robert PH, Mulin E, Mallea P, David R (2010) Apathy diagnosis, assessment, and treatment in Alzheimer’s disease. CNS Neurosci Ther 16:263–271
Rog LA, Park LQ, Harvey DJ, Huang C-J, Mackin S, Farias ST (2014) The independent contributions of cognitive impairment and neuropsychiatric symptoms to everyday function in older adults. Clin Neuropsychol 28:215–236
Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG (2013) The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry 21:685–695
Rotomskis A, Margevičiūtė R, Germanavičius A, Kaubrys G, Budrys V, Bagdonas A (2015) Differential diagnosis of depression and Alzheimer’s disease with the Addenbrooke’s Cognitive Examination-Revised (ACE-R). BMC Neurol 15:1
Rubínová E, Nikolai T, Marková H, Šiffelová K, Laczó J, Hort J, Vyhnálek M (2014) Clock drawing test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work? J Clin Exp Neuropsychol 36:1076–1083
Russo MJ, Iturry M, Sraka MA, Bartoloni L, Carnero Pardo C, Allegri RF (2014) Diagnostic accuracy of the phototest for cognitive impairment and dementia in Argentina. Clin Neuropsychol 28:826–840
Satukijchai C, Senanarong V (2013) Clock drawing test (CDT) and activities of daily living (ADL) questionnaire as a short screening test for dementia in Thai population. J M Assoc Thai = Chotmaihet Thangphaet 96:S39–S46
Scharre DW, Chang SI, Nagaraja HN, Yager-Schweller J, Murden RA (2014) Community cognitive screening using the self-administered gerocognitive examination (SAGE). J Neuropsychiatr Clin Neurosci 26:369–375
Schmitter-Edgecombe M, Parsey C, Lamb R (2014) Development and psychometric properties of the instrumental activities of daily living: compensation scale. Arch Clin Neuropsychol 29:776–792, acu053
Selbaek G, Engedal K, Benth JS, Bergh S (2014) The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatr 26:81–91
Shulman I (2000) Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548–561
Shulman KI, Herrmann N, Brodaty H, Chiu H, Lawlor B, Ritchie K, Scanlan JM (2006) IPA survey of brief cognitive screening instruments. Int Psychogeriatr 18:281–294
Stanciu I, Larsson M, Nordin S, Adolfsson R, Nilsson L-G, Olofsson JK (2014) Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: a longitudinal, population-based study. J Int Neuropsychol Soc 20:209–217
Stella F (2013) Assessment of neuropsychiatric symptoms in dementia: toward improving accuracy. Dementia Neuropsychol 7:244–251
Stella F, Forlenza OV, Laks J, de Andrade LP, de Castilho Cacao J, Govone JS, de Medeiros K, Lyketsos CG (2015) Caregiver report versus clinician impression: disagreements in rating neuropsychiatric symptoms in Alzheimer’s disease patients. Int J Geriatr Psychiatry 30:1230–1237
Storey JE, Rowland JT, Conforti DA, Dickson HG (2004) The Rowland universal dementia assessment scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr 16:13–31
Streit S, Limacher A, Zeller A, Bürge M (2015) Detecting dementia in patients with normal neuropsychological screening by Short Smell Test and Palmo-Mental Reflex Test: an observational study. BMC Geriatr 15:1
Tariq SH, Tumosa N, Chibnall JT, Perry MH, Morley JE (2006) Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder – a pilot study. Am J Geriatr Psychiatry 14:900–910
Ting C, Rajji TK, Ismail Z, Tang-Wai DF, Apanasiewicz N, Miranda D, Mamo D, Mulsant BH (2010) Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late life. PLoS ONE 5:e10151
Tsang RS, Diamond K, Mowszowski L, Lewis SJ, Naismith SL (2012) Using informant reports to detect cognitive decline in mild cognitive impairment. Int Psychogeriatr 24:967–973
Waldron-Perrine B, Axelrod BN (2012) Determining an appropriate cutting score for indication of impairment on the Montreal Cognitive Assessment. Int J Geriatr Psychiatry 27:1189–1194
Weiner MF, Tractenberg RE, Jin S, Gamst A, Thomas RG, Koss E, Thal LJ (2002) Assessing Alzheimer’s disease patients with the Cohen-Mansfield Agitation Inventory: scoring and clinical implications. J Psychiatr Res 36:19–25
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Ismail, Z., Mortby, M.E. (2016). Cognitive and Neuropsychiatric Screening Tests in Older Adults. In: Chiu, H., Shulman, K. (eds) Mental Health and Illness of the Elderly. Mental Health and Illness Worldwide. Springer, Singapore. https://doi.org/10.1007/978-981-10-0370-7_16-1
Download citation
DOI: https://doi.org/10.1007/978-981-10-0370-7_16-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0370-7
Online ISBN: 978-981-10-0370-7
eBook Packages: Springer Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences